• J&J denies the allegations, saying decades of scientific testing and regulatory approvals have shown its talc to be safe and asbestos-free.
• It reiterated the statement as it announced the discontinuation of the product.
Johnson & Johnson will no longer be selling its Talcum powder worldwide from 2023.
This follows 38,000 lawsuits to get Johnson & Johnson to stop selling its talcum powder, which is accused of asbestos contamination linked to cancer.
The powder is widely used by Kenyan mothers to prevent nappy rash.
“...we have made the commercial decision to transition to an all cornstarch-based baby powder...As a result of this transition, talc-based...powder will be discontinued globally in 2023.” read a statement.
The drugmaker said on Thursday (Aug 11), more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits.
"As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby powder portfolio," it said, adding that cornstarch-based baby powder is already sold in countries around the world.
In 2020, J&J announced that it would stop selling its talc Baby Powder in the United States and Canada because demand had fallen in the wake of what it called "misinformation" about the product's safety amid a barrage of legal challenges.